Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2006
03/08/2006CN1745065A 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors
03/08/2006CN1745063A Compound inhibiting dipeptidyl peptidase iv
03/08/2006CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
03/08/2006CN1743322A Diazosulfide derivative, and its synthesizing method and activity for inducing tobacco to resist tobacco mosaic virus
03/08/2006CN1244580C Aminothiazoles and their use as adenosine receptor antagonists
03/08/2006CN1244576C Chemical compounds
03/08/2006CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
03/07/2006US7009057 Method for obtaining pioglitazone as an antidiabetic agent
03/07/2006US7009056 Glaucoma; multiple sclerosis
03/07/2006US7009048 Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
03/07/2006US7008958 Such as 2-bromo-6-methoxy-5-(5-oxazolyl)-1H-indole-3-carboxaldehyde for treating disorders associated with inosine monophosphate dehydrogenase (IMPDH); immunosuppressants, anti-cancer agents
03/07/2006US7008957 6-amino-5-oxo--hexahydropyrrolo[2,1-b]thiazole-3-carbonitrile compounds of given formula; for the treatment of metabohlic disorders such as type 2 diabetes
03/07/2006US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/07/2006US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
03/07/2006US7008946 CCR5 antagonists useful for treating AIDS
03/07/2006US7008945 Amide derivatives
03/07/2006US7008753 Optical recording medium
03/07/2006US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis
03/02/2006WO2006023931A2 Kinase inhibitors
03/02/2006WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006WO2006023460A2 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
03/02/2006WO2006022773A1 Gyrase inhibitors and uses thereof
03/02/2006WO2006022450A1 Remedy for skin disease
03/02/2006WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity
03/02/2006WO2006022374A1 2-phenylpyridine derivative
03/02/2006WO2006021448A1 Novel compounds having an anti-bacterial activity
03/02/2006WO2006021213A2 Vasopressin v1a antagonists
03/02/2006WO2005101838A3 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/02/2006WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
03/02/2006WO2005030766A8 Phenyl - carboxamide compounds useful for treating pain
03/02/2006US20060047114 Azabicyclic amine histamine-3 receptor antagonists
03/02/2006US20060046997 6-Alkenyl -, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
03/02/2006US20060046987 Substituted quinazoline derivatives and their use as inhibitors
03/02/2006US20060046984 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome
03/02/2006DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity
03/02/2006DE102004032567A1 Substituierte 1-Propiolyl-piperazine Substituted 1-piperazine-propiolyl
03/02/2006CA2578168A1 2-phenylpyridine derivative
03/02/2006CA2577528A1 Heterocyclic antiviral compounds
03/02/2006CA2577089A1 Sigma receptor inhibitors
03/02/2006CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006CA2571132A1 Novel compounds having an anti-bacterial activity
03/01/2006EP1630159A1 5-HT7 receptor antagonists
03/01/2006EP1630158A1 5-HT7 receptor antagonists
03/01/2006EP1629842A1 Topical application of thiazolyl amides
03/01/2006EP1628973A2 Processes for preparation of ziprasidone
03/01/2006EP1628970A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/01/2006EP1628666A2 Compouds and uses thereof in modulating amyloid beta
03/01/2006EP1628662A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
03/01/2006EP1628661A2 Modulators of vr1 receptor
03/01/2006EP1462451B1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof
03/01/2006EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases
03/01/2006EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
03/01/2006EP1233962B1 Novel heterocyclic compounds and their use as medicines
03/01/2006EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives
03/01/2006EP0842923B1 Pyrrole derivatives and medicinal composition
03/01/2006CN1742015A Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
03/01/2006CN1742010A Novel chemical compounds
03/01/2006CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors
03/01/2006CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors
03/01/2006CN1741995A Isoindoline derivative
03/01/2006CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1243752C Herbicidal heterocyclic compound
03/01/2006CN1243751C Piperidine compounds as anti-allergic medicine
03/01/2006CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
03/01/2006CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators
03/01/2006CN1243735C 2-lminopyrrolidine derivatives
02/2006
02/28/2006US7005439 Compounds
02/28/2006US7005436 Heterocyclo inhibitors of potassium channel function
02/28/2006US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
02/28/2006US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
02/28/2006CA2180444C Water soluble onium salt of taxo-diterpenoid
02/23/2006WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
02/23/2006WO2006020767A2 Thiazole based inhibitors of atp-utilizing enzymes
02/23/2006WO2006020598A2 Amido compounds and their use as pharmaceuticals
02/23/2006WO2006020156A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease
02/23/2006WO2006019957A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
02/23/2006WO2006019497A2 Sleep-inducing compounds and methods related thereto
02/23/2006WO2006018855A1 Novel antidiabetic compounds
02/23/2006WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/23/2006WO2006018309A1 5-ht7 receptor antagonists
02/23/2006WO2006018308A1 5-ht7 receptor antagonists
02/23/2006WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor
02/23/2006WO2006018188A2 Substituted hydantoins
02/23/2006WO2006004507A3 New benzothiazole derivatives useful for treating cns disorders
02/23/2006WO2005123688A3 3-aminoindazoles
02/23/2006WO2005118557A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/23/2006WO2005116025A3 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders
02/23/2006WO2005110980A3 Aryl sulfones and uses related thereto
02/23/2006WO2005048953A3 Amide derivatives as kinase modulators
02/23/2006US20060041146 Substituted hydantoins
02/23/2006US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides
02/23/2006US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
02/23/2006US20060041123 Antibacterial agents
02/23/2006US20060040998 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
02/23/2006US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione
02/23/2006US20060040995 Method for preparing hydroxypicolinic scid derivatives
02/23/2006US20060040993 Having (i) an infra red spectrum containing peaks at 1549, 759, 600 cm-1; (ii) a Raman spectrum containing peaks at 1338, 1183, 990, 552 cm-1; and/or (iii) an X-ray powder diffraction pattern containing peaks at 6.2, 11.9, 15.9, 19.8, 22.7 degrees 2 theta .
02/23/2006US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
02/23/2006US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use